8 - 29 November 2019: Seminars in Life Sciences (1st CFU) on How to communicate rare diseases
The mini-course will take place every Friday afternoon in Room U0.3 (MO51) – Via Campi 103, Modena.
How to understand, communicate and innovate
in the field of rare diseases
The mini-course, organized as a collaborative activity of the Department of Life Sciences and Sanofi Genzyme, has received the endorsement of Uniamo and will be held by Physicians, Communication professionals, Patient’s Association, Marketing and Open Innovation experts. It aims to provide an overview on the topic of rare diseases and will be conducted in English within the course of Seminars in Life Sciences. 1CFU will be recognized to all participants behind a test pass.
Nov. 8th (14:30-16:30)
1st Module: Research & Development, Mauro A. Ninci - Medical Director, Sanofi Genzyme
2nd Module: Business acceleration and Incubation programs, Federica Draghi - Investment Director, GENEXTRA
Nov. 15th (14:30-16:30)
3rd Module: Medical-Marketing Programs, Michela Paradisi - Rare Disease Specialty Project Manager, Sanofi Genzyme and Marco Rago - Associate Director Medical Affairs Fabry, Sanofi Genzyme
4th Module: Patient Advocacy, Annalisa Scopinaro - UNIAMO President, Simona Bellagambi - EURORDIS representative and Serena Bellaluna - Patient Advocacy, Sanofi Genzyme
Nov. 22nd (14:30-16:30)
5th Module: Communication, Alice Manfredini - Media Relations, Sanofi and Biagio Oppi, Corporate Communication & Media Relations, Alfasigma
6th Module: Institutional Affairs, Giuseppe Secchi - Public Affaires Coordinator, Sanofi Genzyme
Nov. 29th (14:30-16:30)
7th Module: Open Innovation, Stefano Maffei – Polifactory Director, Politecnico di Milano
8th Module: Innovation in Pediatrics, Alberto E. Tozzi - Chief Innovation Officer, Ospedale Pediatrico Bambin Gesù Roma
[Ultimo aggiornamento: 01/11/2019 16:02:49]